RecruitingNot ApplicableNCT05439135

Washed Microbiota Transplantation for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract

An Open-label, Multicenter, Randomized Clinical Trial for Malnutrition After Nonphysiological Reconstruction of the Upper Gastrointestinal Tract: Washed Microbiota Transplantation Via Mid-gut Tube Versus Colonic Transendoscopic Enteral Tube


Sponsor

The Second Hospital of Nanjing Medical University

Enrollment

62 participants

Start Date

Oct 20, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, randomized, multicenter study to evaluate WMT in improving nutritional status in malnourished patients who underwent nonphysiological reconstruction of the upper gastrointestinal tract. In this multicenter trial, sixty-two patients will be enrolled in forteen Chinese sites. Participants will be randomized at a ratio of 1:1 to receive three WMTs through either mid-gut tube or colonic TET. After WMT, each participant will receive free diet plus home enteral nutrition. Home enteral nutrition should last for 2 months at home, with blood, urine and stool samples taken and stored at baseline and 2 months after WMT.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Patients undergone nonphysiological reconstruction of the gastrointestinal tract (such as Billroth-II, Roux-en-Y, Child, Whipple reconstruction)
  • Aged over 18 years old;
  • Malnutrition is assessed by Nutritional Risk Screening 2002 score≥3 and Patient Generated Subjective Global Assessment (PG-SGA) score≥4;
  • Written informed consent;

Exclusion Criteria14

  • Expected survival time \< 3 months;
  • Still on anti-tumor therapy or it is expected during the visit;
  • Complicated with ascites or edema caused by malnutrition;
  • Known organic gastrointestinal disease (e.g., gastrointestinal infection, inflammatory bowel disease, or radiation enteritis);
  • Undergone other gastrointestinal surgery (e.g., enterectomy, enterostomy, or gastrostomy) except appendectomy or anal fistula surgery;
  • Complicated with contraindications of enteral nutrition such as ileus, active gastrointestinal bleeding, and shock;
  • Cannot tolerate gastroscopy or colonoscopy;
  • Severe comorbidities (e.g., diabetes, cardiopulmonary failure, severe liver or or kidney diseases);
  • Complicated with other wasting diseases (e.g., active tuberculosis, hyperthyroidism, diabetes, HIV, active hepatitis, hip fracture, craniocerebral injury, etc.);
  • A history of anti-infective treatment within 30 days before enrollment; or need anti-infective treatment at the time of enrollment; or unwilling to stop taking drugs that affect gut microbes, such as probiotics;
  • Can not tolerate oral enteral nutrition;
  • Women who are pregnant or breastfeeding;
  • Participating in another clinical trial;
  • Deemed unsuitable for inclusion by the investigators.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERwashed microbiota transplantation

Each patient will receive washed microbiota transplantation each day for three consecutive days. After WMT, participants will receive free diet plus home enteral nutrition (solution at a 750ml daily dosage that provides 750 kcal energy) at home for 8 weeks.


Locations(1)

The Second Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05439135


Related Trials